NICHOLAS A GRAY, RATHIKA KRISHNASAMY, DEEPAK L VARDESH, PETER R HOLLETT and CHRIS M ANSTEY Impact of non-traditional phosphate binders and cinacalcet on haemodialysis patient biochemistry, pill burden and cost Nephrology 16
Article first published online: 27 OCT 2011 | DOI: 10.1111/j.1440-1797.2011.01482.x
This cross-sectional study analysed the use of newer phosphate binders sevelamer, cinacalcet, and lanthanum and their impact of serum phosphate lowering in an Australian nephrology clinical practice. These changes have been at an additional cost of AUD 2444/patient per year although serum phosphate and PTH remained unchanged. Data to address clinical end-points of mortality and hospitalization are needed to determine if the cost of these newer agents is warranted.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf